Treatment method with SR18662 significantly reduces expansion and proliferation of CRC cells. SR18662 demonstrates enhanced efficacy in decreasing viability of several CRC mobile strains. Movement cytometry Examination subsequent SR18662 procedure exhibits an increase in cells captured in either S or G2/M phases with the cell cycle and a major rise https://hanneso520glp3.wikimidpoint.com/user